Robotic surgery is no longer a technology of
the future: it has become a standard for managing complex pathologies. In
urology, procedures such as nephrectomy, prostatectomy, and cystectomy
particularly benefit from these innovations, offering enhanced precision and
reduced surgical risks. For over two decades, the da Vinci system has
dominated this field with its proven performance. However, its high cost limits
accessibility. In this context, the Kangduo (KD), a recently developed
surgical robot, emerges as a promising alternative. The question arises: can it
rival the established leader, da Vinci?
The results reveal that although the operating time is longer with the KD system (180 minutes compared to 130 minutes for da Vinci), it presents notable advantages. Specifically, blood loss is reduced, thereby lowering the risk of hemorrhage. Furthermore, postoperative complications are less frequent, with an infection rate of 11.7% compared to 29.1% for da Vinci, and fever rates of 15% compared to 30.5%. Patient satisfaction is comparable between the two systems, exceeding 95% in both groups. Finally, the cost of the KD system is approximately 25-30% of that of the da Vinci system, providing a significant economic advantage.
Can Kangduo compete with Da Vinci?
A total of 201 adult patients who underwent urological surgeries — nephrectomy, cystectomy, or prostatectomy — were selected and divided into two groups based on the system used (Kangduo or da Vinci). The performance of the two robots was compared using several criteria: operating time, blood loss, postoperative complications, and patient satisfaction.The results reveal that although the operating time is longer with the KD system (180 minutes compared to 130 minutes for da Vinci), it presents notable advantages. Specifically, blood loss is reduced, thereby lowering the risk of hemorrhage. Furthermore, postoperative complications are less frequent, with an infection rate of 11.7% compared to 29.1% for da Vinci, and fever rates of 15% compared to 30.5%. Patient satisfaction is comparable between the two systems, exceeding 95% in both groups. Finally, the cost of the KD system is approximately 25-30% of that of the da Vinci system, providing a significant economic advantage.
Kangduo: a promising alternative in robotic surgery
The Kangduo system delivers performance comparable to that of da Vinci, with notable advantages such as reduced blood loss and lower postoperative complication rates. While operating times are currently longer with the KD system, this delay could decrease as surgeons become more familiar with the technology.Last press reviews
COVID-19 and coagulation parameters: a link to mortality?
The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...
Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?
Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...
Endometriosis: the Impact of hormones, sexual practice, and surgical treatments
Endometriosis is a chronic inflammatory disease modulated by estrogen leve...